Ann Scheimann

50 papers receiving 1.2k citations

Peers

Ann Scheimann
Comparison fields: 5 of 87
  • Hepatology 179
  • Aging 34
  • Endocrinology, Diabetes and Metabolism 233
  • Genetics 373
  • Epidemiology 400
Replace Daniel B. Smith with:
Daniel B. Smith United States
Susan Williams United States
Elva Pérez‐Luque Mexico
Heiner Mönig Germany
Maciej Gonciarz Poland
Amy Evenson United States
Nils Heits Germany
Henrik Arnell Sweden
M Ahrens Germany
Wes Spiller United Kingdom
Ann Scheimann relative to Daniel B. Smith United States Daniel B. Smith's profile →
Citations per field
00.5×11.3×
Daniel B. Smith · 1×
Citations per year

Countries citing papers authored by Ann Scheimann

Since Specialization
Citations

This map shows the geographic impact of Ann Scheimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Scheimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Scheimann more than expected).

Fields of papers citing papers by Ann Scheimann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Scheimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Scheimann. The network helps show where Ann Scheimann may publish in the future.

Co-authors

The 25 scholars most cited alongside Ann Scheimann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Scheimann Line = papers co-authored together Ann Scheimann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20242
3 20232
4 202210
5 20221
6 20212
7 20201
8 20207
9 202010
10 20202
11 20123
12 201261
13 20117
14 201028
15 200779
16 200780
17 20067
18 20059
19 20004
20 199734

About Ann Scheimann

Ann Scheimann is a scholar working on Pharmacy, Hepatology, Aging, Genetics and Endocrinology, Diabetes and Metabolism, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Genetic Syndromes and Imprinting (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Epigenetics and DNA Methylation (8 papers), Genetics and Neurodevelopmental Disorders (7 papers), Obesity, Physical Activity, Diet (6 papers), Diet, Metabolism, and Disease (6 papers), Child Nutrition and Feeding Issues (5 papers) and Pediatric Hepatobiliary Diseases and Treatments (5 papers). The work is most often cited by research in Hepatology (179 citations), Aging (34 citations), Endocrinology, Diabetes and Metabolism (233 citations), Genetics (373 citations) and Epidemiology (400 citations). Ann Scheimann has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Jeffrey B. Schwimmer, Susan K. Durham, D.R. Powell, Adisak Suwanichkul, Joel E. Lavine, Katherine P. Yates, Karen F. Murray, Jean P. Molleston, Aynur Ünalp–Arida and Elizabeth M. Brunt. Their work appears in journals such as Journal of Pediatric Gastroenterology and Nutrition, The Journal of Pediatrics, Endocrinology, Hepatology Communications and Orphanet Journal of Rare Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026